Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
KHP Ventures, now rebranded as Meridian Health Ventures, is a transatlantic health tech fund established in 2021 through the NHS Clinical Entrepreneur Programme. The firm is headquartered in London, UK, and focuses on investing in clinical innovators within the Digital Health and MedTech sectors. The fund has approximately €44.7 million in total LP commitments, combining its initial fund and a new transatlantic vehicle. This unique structure allows KHP Ventures to support health tech ventures in both the UK and the US, facilitating the adoption of transformative healthcare solutions at scale.
The organization has a diverse portfolio of 12 companies, emphasizing the importance of generating real-world data and evidence to support broader adoption of health solutions. KHP Ventures leverages its NHS connections to provide portfolio companies with access to clinical validation, real-world data, and NHS adoption pathways, enhancing their credibility and market potential. Notable milestones include partnerships with leading health tech companies and a strong presence in the health tech investment community.
KHP Ventures primarily invests in health tech companies, particularly those involved in Digital Health and MedTech. The firm targets seed and Series A stages, focusing on companies that demonstrate the potential for clinical innovation and market impact. The investment strategy emphasizes generating real-world data and evidence to support the broader adoption of health solutions, which is critical for success in the healthcare sector.
The organization aims to assist ambitious founders in thriving domestically while accelerating their growth in the US market. KHP Ventures seeks to partner with companies that can leverage its NHS anchor for clinical validation and access to NHS adoption pathways. This unique approach not only enhances the credibility of portfolio companies but also positions them for success in both the UK and US healthcare markets.
KHP Ventures has built a diverse portfolio of health tech companies, including:
This portfolio reflects KHP Ventures' commitment to supporting innovative health tech solutions that address critical challenges in healthcare delivery.
Alex Trewby: CEO & Co-Founder of Apian, Alex has extensive experience in health tech and innovation. He has led multiple successful ventures in the healthcare sector, focusing on clinical workflow automation.
Umaima Ahmad: Co-Founder & CEO of 52 North, Umaima has a strong background in surgical robotics and MedTech. She played a pivotal role in securing early investment from KHP Ventures and has been instrumental in the company's growth.
Daniel Dickens: General Partner at KHP Ventures, Daniel brings a wealth of experience in venture capital and health tech investments, focusing on scaling innovative solutions.
Dr. Nadine Haram: General Partner, Dr. Haram has a background in clinical practice and health tech innovation, contributing her expertise to support portfolio companies.
Tim Irish: General Partner, Tim specializes in investment strategy and has a strong track record in supporting health tech startups.
Dr. Pooja Sikka: General Partner, Dr. Sikka has a background in clinical research and health technology, providing valuable insights to portfolio companies.
KHP Ventures prefers pitches to be submitted through their website at khpventures.com. Founders should include a comprehensive deck that outlines their business model, clinical validation, and market strategy. The firm values clarity and detail in the pitch materials.
Response times can vary, but founders can expect to hear back within a few weeks. KHP Ventures encourages warm introductions, particularly from mutual connections in the health tech space, to enhance the likelihood of a successful engagement.
In May 2025, KHP Ventures announced its rebranding to Meridian Health Ventures, launching a transatlantic fund with approximately €44.7 million in total LP commitments. This new fund aims to support health tech innovations from the UK as they scale into the US healthcare market.
Recent portfolio activity includes continued support for companies like Doccla, deepc, Patchwork, Tympa Health, Apian, iFAST Diagnostics, PocDoc, Phare Health, 52 North, and MediShout. The firm has been actively engaging with these companies to facilitate their growth and market adoption.
What are KHP Ventures' investment criteria?
KHP Ventures invests in health tech companies, particularly those in Digital Health and MedTech, focusing on seed and Series A stages. The firm looks for clinical innovators that can leverage NHS connections for validation and market access.
How can I apply or pitch to KHP Ventures?
Founders can pitch to KHP Ventures through their website at khpventures.com. It is advisable to include a detailed business plan and evidence of clinical validation in the pitch.
What makes KHP Ventures different from other investors?
KHP Ventures is unique due to its NHS anchor, which provides portfolio companies with access to clinical validation, real-world data, and NHS adoption pathways. This advantage enhances the credibility and market potential of their investments.
What is the geographic scope of KHP Ventures?
The firm operates primarily in the UK and the US, supporting health tech innovations in both markets and facilitating their growth across the Atlantic.
What is the typical check size for investments?
While specific check sizes are not disclosed, KHP Ventures focuses on seed and Series A investments, which typically range from hundreds of thousands to several million dollars, depending on the stage and needs of the company.
What kind of post-investment involvement does KHP Ventures have?
KHP Ventures actively supports its portfolio companies by providing access to NHS resources, facilitating clinical validation, and assisting in scaling operations in the US market.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.